Breast carcinoma; Intercostobrachial nerve; Axillary lymph node dissection.
乳腺癌；肋间臂神经；腋窝淋巴结清扫。
Taoerqi; breast neoplasm; human breast carcinoma cell lines MCF7; apoptosis.
桃儿七；乳腺癌；人乳腺癌细胞系MCF7；雕亡。
BRMS1 is a tumor metastasis suppressor gene discovered in breast carcinoma cells in 2000.
BRMS1是2000年在乳腺癌细胞中发现的癌转移抑制基因。
To study the expression of PLK1 and PCNA in breast carcinoma and its clinical significance.
目的探讨乳腺癌组织中PLK1、增殖细胞核抗原(pcna)的表达及其临床意义。
Methods The clinical data of 84 patients with breast carcinoma were analyzed retrospectively.
方法对我院84例乳腺癌病人进行回顾性分析。
In a female, unilateral axillary nodes raise the suspicion of an ipsilateral breast carcinoma.
在女性，单侧淋巴结肿大怀疑单侧乳腺癌。
Purpose To study the clinicopathological features of breast carcinoma with responsive granuloma.
目的：研究伴反应性肉芽肿的乳腺癌的临床病理特点。
Objective: Blood supply of breast carcinoma was studied for arterial chemotherapeutics infusion.
目的：通过对乳腺癌肿瘤血供的研究，为动脉灌注化疗奠定基础。
Objective To explore the prevention and treatment of operative complications of breast carcinoma.
目的探讨乳腺癌手术并发症的预防和处理。
Objective To explore the clinical characteristics, treatment and prognosis of male breast carcinoma.
目的探讨男性乳腺癌的特点、治疗及预后。
Objective To evaluate the value of high frequency ultrasonography in the diagnosis of breast carcinoma.
目的探讨高频超声对乳腺癌的诊断价值。
Objective To evaluate the effect of high intensive focused ultrasound (HIFU) on breast carcinoma angiogenesis.
目的观察高强度聚焦超声(HIFU)对乳腺癌组织及其滋养血管的破坏作用。
Conclusion: a part of patients with breast carcinoma were found micrometastasis in their blood and bone marrow.
结论：部分乳腺癌患者骨髓和血液中存在微转移。
Methods Ultrasonographic features of 40 pathologically confirmed breast carcinoma was analyzed retrospectively.
方法回顾分析40例经手术病理证实为乳腺癌的高频声像图表现。
Objective To study the relation between FAK expression and biological behavior or prognosis in breast carcinoma.
目的研究粘着斑激酶（FAK）表达与乳腺癌生物学行为和预后的关系。
It is showed that the detection of tumor mark - ers is a valuable indicator of prediction for the breast carcinoma.
表明这些肿瘤标志物对乳癌病人是有价值的预测指标。
A great deal of studies showed that they have the important role in invasiveness and metastasis of breast carcinoma.
大量研究表明，它们在乳腺癌的浸润和转移中起着极为重要的作用。
The results confirmed that er and CEA served as opposite markers which indi - cate biological behavior of breast carcinoma.
结果表明ER和CEA在乳腺癌生物学行为鉴定上是一对意义相反的标志。
RESULTS: Primary malignant tumors included breast carcinoma (5 cases), lung carcinoma (14 cases) and colon carcinoma (1 case).
结果：原发肿瘤包括乳腺癌5例，肺癌14例，结肠癌1例。
Objective To study the prognostic identification of lymph node negative breast carcinoma by quantitative pathologic technique.
目的探讨定量病理技术对腋淋巴结阴性乳腺癌预后判断的应用价值。
Objective to detect telomerase activity in breast carcinoma by silver-staining telomeric repeat amplification protocol (TRAP).
目的探讨应用银染端粒重复扩增技术(TRAP)检测乳腺癌组织端粒酶活性。
There are some factors that affect the prognosis of the breast carcinoma, for example, size of tumor, status of lymph node, etc.
影响乳腺癌预后的因素很多，如肿瘤大小，淋巴结转移情况等。
Objective To evaluate the diagnostic value of high frequency ultrasonography in axillary lymph nodes metastasis of breast carcinoma.
目的探讨高频超声在乳腺癌腋窝淋巴结转移诊断中的应用价值。
In this trial, women aged at least 45 years with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled.
在这个试验中，入选标准为年龄大于45岁经历保乳手术的浸润性导管癌的患者。
The prognostic value of morphometric parameters in 57 patients with breast carcinoma of different clinical pathological features was studied.
应用图象分析技术测定57例乳腺癌细胞核形态参数，观察它们在不同临床病理状况下与预后的关系。
Conclusions: MMP-2 is an unfavorable prognostic factor in lymph node-negative breast carcinoma patients and it is an important prognostic factor.
结论：MMP - 2蛋白在淋巴结阴性乳腺癌转移复发中起着重要作用，是重要的预后因子。
Combination of the feature of morphology and enhancement dynamics can increase the accuracy of low magnetic field MRI in breast carcinoma diagnosis.
结合分析病变的形态学特征及增强动力学表现，可提高低场MRI乳腺癌的诊断准确率。
Conclusion the rational and scientific combination of multiple modality is important to prolong survival time of the patients with breast carcinoma.
结论应用合理有序的综合治疗和个体化治疗方案可进一步提高乳腺癌疗效。
Conclusion no difference was found between BPBC and single lateral breast carcinoma in treatment, prognosis of BPBC was determined by clinical stages.
结论：BPBC的治疗原则与单侧乳腺癌相比无明显差别，临床分期是判断BPBC预后的主要依据。
Conclusion no difference was found between BPBC and single lateral breast carcinoma in treatment, prognosis of BPBC was determined by clinical stages.
结论：BPBC的治疗原则与单侧乳腺癌相比无明显差别，临床分期是判断BPBC预后的主要依据。
应用推荐